We have a winner for the 2018 compensation sweepstakes.
An SEC filing last week revealed that Stéphane Bancel, who made history bringing his biotech unicorn Moderna to Nasdaq in a historic $604 million IPO and a market valuation of $7.5 billion, grabbed a $58 million compensation package for 2018 — with a chunk of stock options providing the bulk of the upside.
In order to read this article, you must be an Endpoints News subscriber. (It's free to subscribe.)
The best place to read Endpoints News? In your inbox.
Comprehensive daily news report for those who discover, develop, and market drugs. Join 51,200+ biopharma pros who read Endpoints News by email every day.Free Subscription